Abnormal expression of synaptic proteins and neurotrophin-3 in the down syndrome mouse model Ts65Dn

Neuroscience

Volumn 156, Issue 1, 2008, Pages 99-106

  Pollonini, G ^a   Gao, V ^a   Rabe, A ^b   Palminiello, S ^b,c   Albertini, G ^c   Alberini, C M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Down syndrome; memory; neurotrophin; plasticity; synaptic protein; Ts65Dn

Indexed keywords

CYCLIN DEPENDENT KINASE 5; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROTROPHIN 3; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HIPPOCAMPUS; LONG TERM MEMORY; LONG TERM POTENTIATION; MALE; MEMORY DISORDER; MOUSE; NERVE CELL PLASTICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANIMALS, NEWBORN; BRAIN; CYCLIN-DEPENDENT KINASE 5; DISEASE MODELS, ANIMAL; DOWN SYNDROME; FEMALE; HIPPOCAMPUS; MALE; MEMORY DISORDERS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEURONAL PLASTICITY; NEUROTROPHIN 3; SYNAPSES; SYNAPTOPHYSIN;

EID: 51249103592     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.07.025     Document Type: Article

References (71)

1. Alberini C.M. Genes to remember. J Exp Biol 202 (1999) 2887-2891
2. Alberini C.M., Taubenfeld S.M., and Garcia-Osta A. CREB and the CREB-C/EBP-dependent gene expression cascade in long-term memory. Cell Sci Rev 2 (2005) no.2.
3. Allen P.B., Ouimet C.C., and Greengard P. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci U S A 94 (1997) 9956-9961
4. Angelo M., Plattner F., and Giese K.P. Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory. J Neurochem 99 (2006) 353-370
5. Ayala R., Shu T., and Tsai L.H. Trekking across the brain: The journey of neuronal migration. Cell 128 (2007) 29-43
6. Bailey C.H., Bartsch D., and Kandel E.R. Toward a molecular definition of long-term memory storage. Proc Natl Acad Sci U S A 93 (1996) 13445-13452
7. Baxter L.L., Moran T.H., Richtsmeier J.T., Troncoso J., and Reeves R.H. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9 (2000) 195-202
8. Becker L., Mito T., Takashima S., and Onodera K. Growth and development of the brain in Down syndrome. Prog Clin Biol Res 373 (1991) 133-152
9. Belichenko P.V., Masliah E., Kleschevnikov A.M., Villar A.J., Epstein C.J., Salehi A., and Mobley W.C. Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 480 (2004) 281-298
10. Bibb J.A. Role of Cdk5 in neuronal signaling, plasticity, and drug abuse. Neurosignals 12 (2003) 191-199
11. Bimonte-Nelson H.A., Hunter C.L., Nelson M.E., and Granholm A.C. Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome. Behav Brain Res 139 (2003) 47-57
12. Bu B., Li J., Davies P., and Vincent I. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci 22 (2002) 6515-6525
13. Burden S.J. Building the vertebrate neuromuscular synapse. J Neurobiol 53 (2002) 501-511
14. Chang Q., and Gold P.E. Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome. Neurobiol Learn Mem 89 (2007) 167-177
15. Chao M.V. Trophic factors: An evolutionary cul-de-sac or door into higher neuronal function?. J Neurosci Res 59 (2000) 353-355
16. Chhatwal J.P., Myers K.M., Ressler K.J., and Davis M. Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci 25 (2005) 502-506
17. Cheng K., and Ip N.Y. Cdk5: A new player at synapses. Neurosignals 12 (2003) 180-190
18. Cooper J.D., Salehi A., Delcroix J.D., Howe C.L., Belichenko P.V., Chua-Couzens J., Kilbridge J.F., Carlson E.J., Epstein C.J., and Mobley W.C. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A 98 (2001) 10439-10444
19. Cruz J.C., and Tsai L.H. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 10 (2004) 452-458
20. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., and Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40 (2003) 471-483
21. Davisson M.T., Schmidt C., and Akeson E.C. Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res 360 (1990) 263-280
22. Dehmelt L., and Halpain S. The MAP2/Tau family of microtubule-associated proteins. Genome Biol 6 (2005) 204
23. Demas G.E., Nelson R.J., Krueger B.K., and Yarowsky P.J. Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice. Behav Brain Res 90 (1998) 199-201
24. Eichenbaum H. Hippocampus: cognitive processes and neural representations that underlie declarative memory. Neuron 44 (2004) 109-120
25. Elias G.M., and Nicoll R.A. Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins. Trends Cell Biol 17 (2007) 343-352
26. Escorihuela R.M., Fernandez-Teruel A., Vallina I.F., Baamonde C., Lumbreras M.A., Dierssen M., Tobena A., and Florez J. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci Lett 199 (1995) 143-146
27. Evans G.J., and Cousin M.A. Activity-dependent control of slow synaptic vesicle endocytosis by cyclin-dependent kinase 5. J Neurosci 27 (2007) 401-411
28. Fernandez F., Morishita W., Zuniga E., Nguyen J., Blank M., Malenka R.C., and Garner C.C. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 10 (2007) 411-413
29. Fiala J.C., Spacek J., and Harris K.M. Dendritic spine pathology: cause or consequence of neurological disorders?. Brain Res Brain Res Rev 39 (2002) 29-54
30. Fischer A., Sananbenesi F., Spiess J., and Radulovic J. Cdk5: a novel role in learning and memory. Neurosignals 12 (2003) 200-208
31. Fritschy J.M., Schweizer C., Brunig I., and Luscher B. Pre- and post-synaptic mechanisms regulating the clustering of type A gamma-aminobutyric acid receptors (GABAA receptors). Biochem Soc Trans 31 (2003) 889-892
32. Garcia-Osta A., Tsokas P., Pollonini G., Landau E.M., Blitzer R., and Alberini C.M. MuSK expressed in the brain mediates cholinergic responses, synaptic plasticity, and memory formation. J Neurosci 26 (2006) 7919-7932
33. Gong R., Park C.S., Abbassi N.R., and Tang S.J. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem 281 (2006) 18802-18815
34. Graham M.E., Anggono V., Bache N., Larsen M.R., Craft G.E., and Robinson P.J. The in vivo phosphorylation sites of rat brain dynamin I. J Biol Chem 282 (2007) 14695-14707
35. Hanson J.E., Blank M., Valenzuela R.A., Garner C.C., and Madison D.V. The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome. J Physiol 579 (2007) 53-67
36. Hawasli A.H., and Bibb J.A. Alternative roles for Cdk5 in learning and synaptic plasticity. Biotechnol J 2 (2007) 941-948
37. Hilfiker S., Pieribone V.A., Czernik A.J., Kao H.T., Augustine G.J., and Greengard P. Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci 354 (1999) 269-279
38. Insausti A.M., Megias M., Crespo D., Cruz-Orive L.M., Dierssen M., Vallina I.F., Insausti R., and Florez J. Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome. Neurosci Lett 253 (1998) 175-178
39. Katoh-Semba R., Kaisho Y., Shintani A., Nagahama M., and Kato K. Tissue distribution and immunocytochemical localization of neurotrophin-3 in the brain and peripheral tissues of rats. J Neurochem 66 (1996) 330-337
40. Kaufmann W.E., and Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 10 (2000) 981-991
41. Krasuski J.S., Alexander G.E., Horwitz B., Rapoport S.I., and Schapiro M.B. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. Am J Psychiatry 159 (2002) 74-81
42. Kurt M.A., Davies D.C., Kidd M., Dierssen M., and Flórez J. Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Brain Res 858 (2000) 191-197
43. Li C., Brake W.G., Romeo R.D., Dunlop J.C., Gordon M., Buzescu R., Magarinos A.M., Allen P.B., Greengard P., Luine V., and McEwen B.S. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc Natl Acad Sci U S A 101 (2004) 2185-2190
44. Liu L.D.P., Schmidt C., Billings T., and Davisson M. Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome. Biotechniques 35 (2003) 1170-1180
45. Lorenzi H.A., and Reeves R.H. Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res 1104 (2006) 153-159
46. Luo J., Wang Y., Yasuda R.P., Dunah A.W., and Wolfe B.B. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 51 (1997) 79-86
47. Maisonpierre P.C., Belluscio L., Friedman B., Alderson R.F., Wiegand S.J., Furth M.E., Lindsay R.M., and Yancopoulos G.D. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5 (1990) 501-509
48. Nguyen M.D., Lariviere R.C., and Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30 (2001) 135-147
49. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., and Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 (1999) 615-622
50. Pearlson G.D., Breiter S.N., Aylward E.H., Warren A.C., Grygorcewicz M., Frangou S., Barta P.E., and Pulsifer M.B. MRI brain changes in subjects with Down syndrome with and without dementia. Dev Med Child Neurol 40 (1998) 326-324
51. Perry E.K., Perry R.H., Smith C.J., Purohit D., Bonham J., Dick D.J., Candy J.M., Edwardson J.A., and Fairbairn A. Cholinergic receptors in cognitive disorders. Can J Neurol Sci 13 (1986) 521-527
52. Pinter J.D., Brown W.E., Eliez S., Schmitt J.E., Capone G.T., and Reiss A.L. Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study. Neurology 56 (2001) 972-974
53. Pinter J.D., Eliez S., Schmitt J.E., Capone G.T., and Reiss A.L. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am J Psychiatry 158 (2001) 1659-1665
54. Purpura D.P. Normal and aberrant development of synaptic pathways in human hippocampus. Trans Am Neurol Assoc 98 (1973) 224-226
55. Purpura D.P. Normal and aberrant neuronal development in the cerebral cortex of human fetus and young infant. UCLA Forum Med Sci 18 (1975) 141-169
56. Raz N., Torres I.J., Briggs S.D., Spencer W.D., Thornton A.E., Loken W.J., Gunning F.M., McQuain J.D., Driesen N.R., and Acker J.D. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45 (1995) 356-366
57. Reeves R.H., Irving N.G., Moran T.H., Wohn A., Kitt C., Sisodia S.S., Schmidt C., Bronson R.T., and Davisson M.T. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11 (1995) 177-184
58. Riedel G., Platt B., and Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 140 (2003) 1-47
59. Robertson R.T., Baratta J., Yu J., and Guthrie K.M. A role for neurotrophin-3 in targeting developing cholinergic axon projections to cerebral cortex. Neuroscience 143 (2006) 523-539
60. Roubertoux P.L., and Kerdelhue B. Trisomy 21: from chromosomes to mental retardation. Behav Genet 36 (2006) 346-354
61. Sarrouilhe D., di Tommaso A., Metaye T., and Ladeveze V. Spinophilin: from partners to functions. Biochimie 88 (2006) 1099-1113
62. Seregaza Z., Roubertoux P.L., Jamon M., and Soumireu-Mourat B. Mouse models of cognitive disorders in trisomy 21: a review. Behav Genet 36 (2006) 387-404
63. Shimazu K., Zhao M., Sakata K., Akbarian S., Bates B., Jaenisch R., and Lu B. NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis. Learn Mem 13 (2006) 307-315
64. Sylvester P.E. The hippocampus in Down's syndrome. J Ment Defic Res 27 (1983) 227-236
65. Tartaglia N., Du J., Tyler W.J., Neale E., Pozzo-Miller L., and Lu B. Protein synthesis-dependent and -independent regulation of hippocampal synapses by brain-derived neurotrophic factor. J Biol Chem 276 (2001) 37585-37593
66. Taubenfeld S.M., Stevens K.A., Pollonini G., Ruggiero J., and Alberini C.M. Profound molecular changes following hippocampal slice preparation: loss of AMPA receptor subunits and uncoupled mRNA/protein expression. J Neurochem 81 (2002) 1348-1360
67. Valtorta F., Pennuto M., Bonanomi D., and Benfenati F. Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis?. Bioessays 26 (2004) 445-453
68. Vicari S. Motor development and neuropsychological patterns in persons with Down syndrome. Behav Genet 36 (2006) 355-364
69. Wisniewski K.E., Laure-Kamionowska M., and Wisniewski H.M. Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome. N Engl J Med 311 (1984) 1187-1188
70. Wisniewski K.E. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am J Med Genet Suppl 7 (1990) 274-281
71. Yamada K., Mizuno M., and Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci 70 (2002) 735-744